Turner, Martin R., Grosskreutz, Julian, Kassubek, Jan, Abrahams, Sharon, Agosta, Federica, Benatar, Michael, Filippi, Massimo, Goldstein, Laura H., van den Heuvel, Martijn, Kalra, Sanjay, Lulé, Dorothée, Mohammadi, Bahram, Atassi, Nazem, Bede, Peter, Benali, Habib, Enzinger, Christian, Gaser, Christian, Jelsone-Swain, Laura, Müller, Hans-Peter, Orrell, Richard W., Pradat, Pierre-François, Prudlo, Johannes, Ropele, Stefan, Sharma, Rakesh, Silani, Vincenzo, Simmons, Andrew, Smith, Stephen, Teipel, Stefan, Toosy, Ahmed, Tsermentseli, Stella, Van Damme, Philip, Verstraete, Esther, Welsh, Robert and Wittstock, Matthias (2011) Towards a neuroimaging biomarker for amyotrophic lateral sclerosis. The Lancet Neurology, 10 (5). pp. 400-403. ISSN 1474-4422 (doi:https://doi.org/10.1016/S1474-4422(11)70049-7)

Full text not available from this repository.

Abstract

[Comment]

Item Type:	Article
Additional Information:	[1] Comment. [2] Lead authors: Martin R Turner, Julian Grosskreutz, Jan Kassubek, Sharon Abrahams, Federica Agosta, Michael Benatar, Massimo Filippi, Laura H Goldstein, Martijn van den Heuvel, Sanjay Kalra, Dorothée Lulé, Bahram Mohammadi - for the first Neuroimaging Symposium in ALS (NISALS). NISALS contributors: Nazem Atassi (Neurology Clinical Trials Unit, Massachusetts General Hospital- Harvard Medical School, Boston, MA, USA); Peter Bede (Department of Neurology, Trinity College Dublin, Dublin, Ireland); Habib Benali (Laboratoire d’Imagerie Fonctionnelle, INSERM, Paris, France); Christian Enzinger (Department of Neurology, Medical University of Graz, Graz, Austria); Christian Gaser (Department of Psychiatry, Friedrich-Schiller-University of Jena, Jena, Germany); Laura Jelsone-Swain (Department of Radiology, University of Michigan, MI, USA); Hans-Peter Müller (Department of Neurology, University of Ulm, Ulm, Germany); Richard W Orrell (University Department of Clinical Neurosciences, Institute of Neurology, University College London, London, UK); Pierre-François Pradat (Paris ALS Centre, Hôpital de la Pitié-Salpêtrière, Paris, France); Johannes Prudlo (Department of Neurology, University of Rostock and DZNE, Rostock, Germany); Stefan Ropele (Department of Neurology, Medical University of Graz, Graz, Austria); Rakesh Sharma (Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK); Vincenzo Silani (Department of Neurology, Universita’ degli Studi di Milano–IRCCS Istituto Auxologico Italiano, Milano, Italy); Andrew Simmons (Department of Neuroimaging, King’s College London, Institute of Psychiatry, London, UK); Stephen Smith (Nuffi eld Department of Clinical Neurosciences and Centre for Functional Magnetic Resonance Imaging of the Brain, University of Oxford, Oxford, UK); Stefan Teipel (Department of Psychiatry, University of Rostock and DZNE, German Center for Neurodegenerative Disorders, Rostock, Germany); Ahmed Toosy (University Department of Clinical Neurosciences, Institute of Neurology, University College London, London, UK); Stella Tsermentseli (King’s College London, MRC Centre for Neurodegeneration Research, Institute of Psychiatry, London, UK); Philip Van Damme (Neurology Department, Leuven University Hospital and Vesalius Research Center, VIB, Leuven, Belgium); Esther Verstraete (Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Netherlands); Robert Welsh (Departments of Radiology and Psychiatry, University of Michigan, MI, USA); Matthias Wittstock (Department of Neurology, University of Rostock and DZNE, German Center for Neurodegenerative Disorders, Rostock, Germany).
Uncontrolled Keywords:	neuroimaging biomarker, amyotrophic lateral sclerosis, (ALS), NIALS
Subjects:	R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
Pre-2014 Departments:	School of Health & Social Care School of Health & Social Care > Department of Psychology & Counselling
Related URLs:	Publisher Organisation
Last Modified:	14 Oct 2016 09:22
URI:	http://gala.gre.ac.uk/id/eprint/9144

Actions (login required)

View Item